{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T18:10:53Z","timestamp":1793988653734,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["212102310825"],"award-info":[{"award-number":["212102310825"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300420072"],"award-info":[{"award-number":["242300420072"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04493-x","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:55:33Z","timestamp":1763463333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and treatment of patients with overlapping MOG and anti-NMDAR encephalitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yutao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"2","key":"4493_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15(2):89\u2013102.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"4493_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, Pr\u00f6bstel AK, Aktas O, Alexopoulos H, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021;20(9):762\u201372.","journal-title":"Lancet Neurol"},{"issue":"11","key":"4493_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045\u201357.","journal-title":"Lancet Neurol"},{"issue":"3","key":"4493_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of Myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382.","journal-title":"Lancet Neurol"},{"issue":"7","key":"4493_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757\u201368.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4493_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","volume":"38","author":"JL Banks","year":"2007","unstructured":"Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials. Stroke. 2007;38:1091\u20136.","journal-title":"Stroke"},{"issue":"7","key":"4493_CR7","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-3073","volume":"11","author":"H Jin","year":"2023","unstructured":"Jin H, Lu Q, Gao F, Hao H. Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review. Ann Transl Med. 2023;11(7):282.","journal-title":"Ann Transl Med"},{"issue":"4","key":"4493_CR8","volume":"8","author":"N Molazadeh","year":"2022","unstructured":"Molazadeh N, Bose G, Lotan I, Levy M. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a systematic review. Mult Scler J. 2022;8(4):20552173221128170.","journal-title":"Mult Scler J"},{"key":"4493_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10072-020-04942-0","volume":"42","author":"D Nan","year":"2021","unstructured":"Nan D, Zhang Y, Han J, Jin T. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody\u2013associated encephalomyelitis: a case report and review of the literature. Neurol Sci. 2021;42:847\u201355.","journal-title":"Neurol Sci"},{"issue":"31","key":"4493_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021238","volume":"99","author":"L Du","year":"2020","unstructured":"Du L, Wang H, Zhou H, Chang H, Wei Y, Cong H, et al. Anti-NMDA receptor encephalitis concomitant with Myelin oligodendrocyte glycoprotein antibody diseases: a retrospective observational study. Medicine. 2020;99(31): e21238.","journal-title":"Medicine."},{"issue":"4","key":"4493_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103057","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M. Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis. Autoimmun Rev. 2022;21(4):103057.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"4493_CR12","first-page":"581","volume":"58","author":"S Gong","year":"2020","unstructured":"Gong S, Zhang WH, Ren HT, Li JW, Zhou J, Cheng H, et al. Clinical observation on the overlapping syndrome of Myelin oligodendrocyte glycoprotein antibody and anti-N-methyl-D aspartate receptor in children. Zhonghua Er Ke Za Zhi. 2020;58(7):581\u20135.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"4493_CR13","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000458","volume":"5","author":"A Salovin","year":"2018","unstructured":"Salovin A, Glanzman J, Roslin K, Armangue T, Lynch DR, Panzer JA. Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurol Neuroimmunol Neuroinflamm. 2018;5(4):e458.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"4493_CR14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A, Mattozzi S, C\u00e1rceles-Cordon M, Martinez-Heras E, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17(9):760\u201372.","journal-title":"Lancet Neurol"},{"issue":"9","key":"4493_CR15","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1007\/s10072-021-05395-9","volume":"42","author":"C Gunawardhana","year":"2021","unstructured":"Gunawardhana C, Nanayakkara G, Gamage D, Withanage I, Bandara M, Siriwimala C, et al. Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a case report. Neurol Sci. 2021;42(9):3527\u201330.","journal-title":"Neurol Sci"},{"issue":"23","key":"4493_CR16","doi-asserted-by":"publisher","first-page":"e2262","DOI":"10.1212\/WNL.0000000000012931","volume":"97","author":"C Valencia Sanchez","year":"2021","unstructured":"Valencia Sanchez C, Theel E, Binnicker M, Toledano M, McKeon A. Autoimmune encephalitis after SARS-CoV-2 infection: case frequency, findings, and outcomes. Neurology. 2021;97(23):e2262-8.","journal-title":"Neurology"},{"issue":"7","key":"4493_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.nrl.2022.08.002","volume":"38","author":"A Sanchez-Larsen","year":"2022","unstructured":"Sanchez-Larsen A, Rojas-Bartolom\u00e9 L, Fern\u00e1ndez-Valiente M, Sopelana D. Anti-NMDA-R encephalitis post-COVID-19: case report and proposed physiopathologic mechanism. Neurologia (Engl Ed). 2022;38(7):513\u20136.","journal-title":"Neurologia (Engl Ed)"},{"issue":"1","key":"4493_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-02831-0","volume":"14","author":"V Vasilevska","year":"2024","unstructured":"Vasilevska V, Guest PC, Szardenings M, Benros ME, Steiner J. Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis. Transl Psychiatry. 2024;14(1):139.","journal-title":"Transl Psychiatry"},{"issue":"11","key":"4493_CR19","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG\u2013associated disorders. JAMA Neurol. 2018;75(11):1355\u201363.","journal-title":"JAMA Neurol"},{"issue":"8","key":"4493_CR20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2169\/internalmedicine.8709-21","volume":"61","author":"T Ide","year":"2022","unstructured":"Ide T, Kawanami T, Eriguchi M, Hara H. SARS-CoV-2-related myelin oligodendrocyte glycoprotein antibody-associated disease: a case report and literature review. Intern Med. 2022;61(8):1253\u20138.","journal-title":"Intern Med"},{"key":"4493_CR21","doi-asserted-by":"publisher","DOI":"10.1177\/11795735231167869","volume":"15","author":"O Mirmosayyeb","year":"2023","unstructured":"Mirmosayyeb O, Ghaffary EM, Dehghan MS, Ghoshouni H, Bagherieh S, Barzegar M, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease and COVID-19: a systematic review. J Cent Nerv Syst Dis. 2023;15:11795735231167869.","journal-title":"J Cent Nerv Syst Dis"},{"key":"4493_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.578011","volume":"375","author":"F Bosello","year":"2023","unstructured":"Bosello F, Marastoni D, Pizzini FB, Zaffalon C, Zuliani A, Turri G, et al. Atypical myelin oligodendrocyte glycoprotein antibody\u2013associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: case report and literature review. J Neuroimmunol. 2023;375:578011.","journal-title":"J Neuroimmunol"},{"key":"4493_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.799454","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Wang M, Li H, Wang J, Zhang Q, Zhou D, et al. Case report: overlapping syndrome of anti-NMDAR encephalitis and MOG inflammatory demyelinating disease in a patient with human herpesviruses 7 infection. Front Immunol. 2022;13:799454.","journal-title":"Front Immunol"},{"key":"4493_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149987","volume":"14","author":"JX Yang","year":"2023","unstructured":"Yang JX, Yang MM, Han YJ, Gao CH, Cao J. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review. Front Immunol. 2023;14:1149987.","journal-title":"Front Immunol"},{"issue":"1","key":"4493_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ijgo.16028","volume":"169","author":"PB Nha","year":"2025","unstructured":"Nha PB, Tu NP, Ha NV, Hien DTT, Phuong NTT, Son NA, et al. Anti-NMDA receptor autoimmune encephalitis associated with ovarian teratoma: a case series and literature review. Int J Gynaecol Obstet. 2025;169(1):23\u201330.","journal-title":"Int J Gynaecol Obstet"},{"key":"4493_CR26","doi-asserted-by":"publisher","first-page":"1279211","DOI":"10.3389\/fneur.2023.1279211","volume":"14","author":"Q Kang","year":"2024","unstructured":"Kang Q, Kang H, Liu S, Feng M, Zhou Z, Jiang Z, et al. Clinical characteristics of Chinese pediatric patients positive for anti-NMDAR and MOG antibodies: a case series. Front Neurol. 2024;14:1279211.","journal-title":"Front Neurol"},{"issue":"1","key":"4493_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","volume":"77","author":"P Waters","year":"2020","unstructured":"Waters P, Fadda G, Woodhall M, O\u2019Mahony J, Brown RA, Castro DA, et al. Serial anti\u2013myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. 2020;77(1):82\u201393.","journal-title":"JAMA Neurol"},{"key":"4493_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140872","volume":"14","author":"Q Kang","year":"2023","unstructured":"Kang Q, Liao H, Yang L, Fang H, Ning Z, Liao C, et al. Clinical analysis of 173 pediatric patients with antibody-mediated autoimmune diseases of the central nervous system: a single-center cohort study. Front Immunol. 2023;14:1140872.","journal-title":"Front Immunol"},{"key":"4493_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120729","volume":"451","author":"N Takegami","year":"2023","unstructured":"Takegami N, Murai H, Mori H, Yamaguchi-Takegami N, Toda T, Iwata NK, et al. Multiple cortical lesions with grainy enhancement of magnetic resonance imaging in anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated encephalitis with seizures (FLAMES). J Neurol Sci. 2023;451:120729.","journal-title":"J Neurol Sci"},{"issue":"45","key":"4493_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035948","volume":"102","author":"Q Fu","year":"2023","unstructured":"Fu Q, Wang G, Che F, Li D, Wang S. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures overlaying anti-N-methyl-D-aspartate receptor encephalitis: a case report. Medicine. 2023;102(45):e35948.","journal-title":"Medicine"},{"key":"4493_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.711376","volume":"12","author":"J Ding","year":"2021","unstructured":"Ding J, Li X, Tian Z. Clinical features of coexisting anti-NMDAR and MOG antibody-associated encephalitis: a systematic review and meta-analysis. Front Neurol. 2021;12:711376.","journal-title":"Front Neurol"},{"key":"4493_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.msard.2018.12.001","volume":"28","author":"J Zhou","year":"2019","unstructured":"Zhou J, Lu X, Zhang Y, Ji T, Jin Y, Xu M, et al. Follow-up study on Chinese children with relapsing MOG-IgG-associated central nervous system demyelination. Mult Scler Relat Disord. 2019;28:4\u201310.","journal-title":"Mult Scler Relat Disord"},{"key":"4493_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.msard.2018.01.007","volume":"20","author":"S Fan","year":"2018","unstructured":"Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, et al. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord. 2018;20:144\u201352.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"4493_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1674-2","volume":"16","author":"T Ziemssen","year":"2019","unstructured":"Ziemssen T, Akg\u00fcn K, Br\u00fcck W. Molecular biomarkers in multiple sclerosis. J Neuroinflammation. 2019;16(1):272.","journal-title":"J Neuroinflammation"},{"key":"4493_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646940","volume":"12","author":"T Zrzavy","year":"2021","unstructured":"Zrzavy T, H\u00f6ftberger R, Wimmer I, Berger T, Rommer P, Macher S. Longitudinal CSF findings in autoimmune encephalitis\u2014a monocentric cohort study. Front Immunol. 2021;12:646940.","journal-title":"Front Immunol"},{"key":"4493_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.msard.2018.12.017","volume":"28","author":"E Sarigecili","year":"2019","unstructured":"Sarigecili E, Cobanogullari MD, Komur M, Okuyaz C. A rare concurrence: antibodies against myelin oligodendrocyte glycoprotein and N-methyl-d-aspartate receptor in a child. Mult Scler Relat Disord. 2019;28:101\u20133.","journal-title":"Mult Scler Relat Disord"},{"key":"4493_CR37","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.msard.2020.102468","volume":"46","author":"A Cherian","year":"2020","unstructured":"Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B, Coexistent MOG. NMDAR, CASPR2 antibody positivity: triumph over the triumvirate. Mult Scler Relat Disord. 2020;46:102468.","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"4493_CR38","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1177\/1352458519837705","volume":"25","author":"S Salama","year":"2019","unstructured":"Salama S, Khan M, Pardo S, Izbudak I, Levy M. MOG antibody\u2013associated encephalomyelitis\/encephalitis. Mult Scler J. 2019;25(11):1427\u201333.","journal-title":"Mult Scler J"},{"issue":"2","key":"4493_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ana.26549","volume":"93","author":"C Valencia-Sanchez","year":"2023","unstructured":"Valencia-Sanchez C, Guo Y, Krecke KN, Chen JJ, Redenbaugh V, Montalvo M, et al. Cerebral cortical encephalitis in myelin oligodendrocyte glycoprotein antibody\u2010associated disease. Ann Neurol. 2023;93(2):297\u2013302.","journal-title":"Ann Neurol"},{"issue":"5","key":"4493_CR40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/jnnp-2017-316822","volume":"89","author":"OR Phillips","year":"2018","unstructured":"Phillips OR, Joshi SH, Narr KL, Shattuck DW, Singh M, Di Paola M, et al. Superficial white matter damage in anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2018;89(5):518\u201325.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4493_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/IJGM.S397429","volume":"16","author":"L Nguyen","year":"2023","unstructured":"Nguyen L, Wang C. Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies. Int J Gen Med. 2023;16:7\u201321.","journal-title":"Int J Gen Med"},{"issue":"21","key":"4493_CR42","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","volume":"90","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 2018;90(21):e1858-69.","journal-title":"Neurology."},{"key":"4493_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103447","volume":"58","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong S, Ren C, Xiaotun R. Pediatric anti-N-methyl-D-aspartate receptor encephalitis with MOG-Ab co-existence: relapse propensity and treatability. Mult Scler Relat Disord. 2022;58:103447.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"4493_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/cei\/uxad109","volume":"215","author":"BQ Du","year":"2024","unstructured":"Du BQ, Lai QL, Li EC, Cai MT, Fang GL, Shen CH, et al. Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports. Clin Exp Immunol. 2024;215(1):27\u201336.","journal-title":"Clin Exp Immunol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04493-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:03:58Z","timestamp":1763507038000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04493-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4493"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04493-x","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Ethics Committee Reference: 2021-KY-0822-002). Written informed consent was obtained from all participating patients. For participants under the age of 16, consent was provided by their parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants included in the study. For individuals under the age of 18, consent was provided by their parents or legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"472"}}